UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2021

 

 

 

ESGEN Acquisition Corporation

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-40927   98-1601409
(State or other jurisdiction of incorporation
or organization)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

 

5956 Sherry Lane
Suite 1400
Dallas, TX 75225
(214) 987-6100
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

 

Not Applicable 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbols   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant   ESACU   The Nasdaq Stock Market LLC
Class A ordinary shares included as part of the units   ESAC   The Nasdaq Stock Market LLC
Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   ESACW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On November 12, 2021, ESGEN Acquisition Corporation posted a presentation to its corporate website at www.esgen-spac.com, a copy of which is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1 Investor Presentation

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 12, 2021

 

  ESGEN ACQUISITION CORPORATION
   
  By: /s/ Nader Daylami 
  Name: Nader Daylami 
  Title: Chief Financial Officer

 

 

 

ESGEN Acquisition (NASDAQ:ESACU)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more ESGEN Acquisition Charts.
ESGEN Acquisition (NASDAQ:ESACU)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more ESGEN Acquisition Charts.